Brief: Nautilus Biotechnology Q4 EPS USD -0.14
28/02/2024 13:00
Feb 28 (Reuters) - Nautilus Biotechnology Q4 operating expenses USD 20.001 million. * Q4 net income USD -17.024 million
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11